![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF608 |
Gene summary for ZNF608 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF608 | Gene ID | 57507 |
Gene name | zinc finger protein 608 | |
Gene Alias | NY-REN-36 | |
Cytomap | 5q23.2 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | B3KPE6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57507 | ZNF608 | P2T-E | Human | Esophagus | ESCC | 2.37e-07 | 7.21e-02 | 0.1177 |
57507 | ZNF608 | P4T-E | Human | Esophagus | ESCC | 1.73e-03 | 8.14e-02 | 0.1323 |
57507 | ZNF608 | P8T-E | Human | Esophagus | ESCC | 2.21e-09 | 2.31e-01 | 0.0889 |
57507 | ZNF608 | P10T-E | Human | Esophagus | ESCC | 2.46e-05 | 5.25e-02 | 0.116 |
57507 | ZNF608 | P11T-E | Human | Esophagus | ESCC | 9.11e-03 | 1.11e-01 | 0.1426 |
57507 | ZNF608 | P12T-E | Human | Esophagus | ESCC | 4.44e-16 | 3.28e-01 | 0.1122 |
57507 | ZNF608 | P15T-E | Human | Esophagus | ESCC | 8.96e-09 | 1.60e-01 | 0.1149 |
57507 | ZNF608 | P16T-E | Human | Esophagus | ESCC | 3.82e-04 | 3.01e-02 | 0.1153 |
57507 | ZNF608 | P21T-E | Human | Esophagus | ESCC | 7.49e-08 | 1.26e-01 | 0.1617 |
57507 | ZNF608 | P24T-E | Human | Esophagus | ESCC | 1.78e-04 | 4.43e-02 | 0.1287 |
57507 | ZNF608 | P26T-E | Human | Esophagus | ESCC | 1.81e-14 | 2.08e-01 | 0.1276 |
57507 | ZNF608 | P27T-E | Human | Esophagus | ESCC | 1.45e-15 | 1.60e-01 | 0.1055 |
57507 | ZNF608 | P28T-E | Human | Esophagus | ESCC | 1.13e-05 | 9.20e-02 | 0.1149 |
57507 | ZNF608 | P32T-E | Human | Esophagus | ESCC | 1.39e-13 | 1.22e-01 | 0.1666 |
57507 | ZNF608 | P36T-E | Human | Esophagus | ESCC | 1.41e-03 | 2.07e-01 | 0.1187 |
57507 | ZNF608 | P40T-E | Human | Esophagus | ESCC | 1.26e-05 | 1.22e-01 | 0.109 |
57507 | ZNF608 | P48T-E | Human | Esophagus | ESCC | 1.53e-02 | 4.47e-02 | 0.0959 |
57507 | ZNF608 | P52T-E | Human | Esophagus | ESCC | 6.33e-11 | 5.29e-02 | 0.1555 |
57507 | ZNF608 | P54T-E | Human | Esophagus | ESCC | 2.60e-05 | 7.49e-02 | 0.0975 |
57507 | ZNF608 | P57T-E | Human | Esophagus | ESCC | 2.53e-10 | 1.51e-01 | 0.0926 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF608 | insertion | Frame_Shift_Ins | novel | c.1262_1263insCAGAAGCACTCCCACTACCCCTCAAGGGAAACCAGAGACT | p.Pro422ArgfsTer17 | p.P422Rfs*17 | Q9ULD9 | protein_coding | TCGA-A8-A06T-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD | ||
ZNF608 | deletion | In_Frame_Del | c.127_129delNNN | p.Lys43del | p.K43del | Q9ULD9 | protein_coding | TCGA-AR-A256-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | PD | |||
ZNF608 | deletion | In_Frame_Del | c.127_129delAAG | p.Lys43del | p.K43del | Q9ULD9 | protein_coding | TCGA-D8-A1Y1-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | tamoxiphen | PD | |||
ZNF608 | deletion | In_Frame_Del | c.114_125delNNNNNNNNNNNN | p.Asp38_Leu41del | p.D38_L41del | Q9ULD9 | protein_coding | TCGA-E2-A14W-01 | Breast | breast invasive carcinoma | Male | >=65 | I/II | Chemotherapy | cytoxan | SD | |||
ZNF608 | SNV | Missense_Mutation | novel | c.2346N>G | p.Ser782Arg | p.S782R | Q9ULD9 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ZNF608 | SNV | Missense_Mutation | rs756460319 | c.2045N>T | p.Ala682Val | p.A682V | Q9ULD9 | protein_coding | tolerated(0.74) | benign(0) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
ZNF608 | SNV | Missense_Mutation | c.1920G>C | p.Lys640Asn | p.K640N | Q9ULD9 | protein_coding | deleterious(0.02) | possibly_damaging(0.889) | TCGA-IR-A3LA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
ZNF608 | SNV | Missense_Mutation | c.1279G>C | p.Glu427Gln | p.E427Q | Q9ULD9 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-IR-A3LA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
ZNF608 | SNV | Missense_Mutation | novel | c.1806N>C | p.Leu602Phe | p.L602F | Q9ULD9 | protein_coding | tolerated(0.23) | benign(0.106) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF608 | SNV | Missense_Mutation | novel | c.1015N>T | p.Pro339Ser | p.P339S | Q9ULD9 | protein_coding | tolerated(0.07) | probably_damaging(0.999) | TCGA-MA-AA3X-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |